Lipid nanoparticle-mediated drug delivery to the brain

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Engineering precision nanoparticles for drug delivery

Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933 · see citing works

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644 · see citing works

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396 · see citing works

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076 · see citing works

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · see citing works

The blood-brain barrier

Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437 · see citing works

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047 · see citing works

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders

Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · see citing works

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works

Toxicity of cationic lipids and cationic polymers in gene delivery

Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286 · see citing works

The blood–brain barrier: an overview

Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,276 · see citing works

Progress and challenges towards targeted delivery of cancer therapeutics

Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220 · see citing works

Rational design of cationic lipids for siRNA delivery

Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · see citing works

Phenotypic Heterogeneity of the Endothelium

Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,744 · see citing works

Biological Activity of Ionic Liquids and Their Application in Pharmaceutics and Medicine

Egorova, K. S., Gordeev, E. G., & Ananikov, V. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00562 · Cited by 1,666 · see citing works

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636 · see citing works

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609 · see citing works

Receptor-Mediated Endocytosis: Concepts Emerging from the LDL Receptor System

Goldstein, J. L., Brown, M. S., Anderson, R. G. W., Russell, D. W., & Schneider, W. J. (1985) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.01.110185.000245 · Cited by 1,600 · see citing works

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

Culver, K. W., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E. H., & Blaese, R. M. (1992) · Science · doi:10.1126/science.1317968 · Cited by 1,506 · see citing works

Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging

Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448 · see citing works

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267 · see citing works

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261 · see citing works

Challenges in Development of Nanoparticle-Based Therapeutics

Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173 · see citing works

RNAi therapeutics: a potential new class of pharmaceutical drugs

Bumcrot, D. A., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006) · Nature Chemical Biology · doi:10.1038/nchembio839 · Cited by 1,086 · see citing works

Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic

Puri, A., Loomis, K. H., Smith, B. J., Lee, J. H., Yavlovich, A., Heldman, E., & Blumenthal, R. P. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,075 · see citing works

Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages

Mohammadi‐Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 975 · see citing works

Lipid-like materials for low-dose, in vivo gene silencing

Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969 · see citing works

Current Strategies for Brain Drug Delivery

Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954 · see citing works

A Neurovascular Niche for Neurogenesis after Stroke

Ohab, J. J., Fleming, S., Blesch, A., & Carmichael, S. T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4323-06.2006 · Cited by 878 · see citing works

The function of α-synuclein

Bendor, J. T., Logan, T. P., & Edwards, R. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.004 · Cited by 825 · see citing works

Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN

Hinderer, C., Katz, N., Buza, E. L., Dyer, C., Goode, T., Bell, P., Richman, L. K., & Wilson, J. M. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.015 · Cited by 814 · see citing works

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801 · see citing works

mRNA-based therapeutics: powerful and versatile tools to combat diseases

Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 801 · see citing works

Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs

Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., & Anderson, D. G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b02497 · Cited by 785 · see citing works

Application of liposomes in medicine and drug delivery

Daraee, H., Etemadi, A., Kouhi, M., Alimirzalu, S., & Akbarzadeh, A. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.953633 · Cited by 767 · see citing works

Evaluation of intranasal delivery route of drug administration for brain targeting

Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 756 · see citing works

Monocarboxylate transporters in the central nervous system: distribution, regulation and function

Pierre, K., & Pellerin, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03168.x · Cited by 744 · see citing works

Receptor-mediated endocytosis: insights from the lipoprotein receptor system.

Brown, M. S., & Goldstein, J. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3330 · Cited by 711 · see citing works

Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in Stroke

Knowland, D., Arac, A., Sekiguchi, K. J., Hsu, M., Lutz, S. E., Perrino, J., Steinberg, G. K., Barres, B. A., Nimmerjahn, A., & Agalliu, D. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.003 · Cited by 703 · see citing works

A Comprehensive Review on Current Advances in Peptide Drug Development and Design

Lee, A. C.-L., Harris, J. L., Khanna, K. K., & Hong, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102383 · Cited by 692 · see citing works

Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA

Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685 · see citing works

On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA

Kulkarni, J. A., Darjuan, M. M., Mercer, J. E., Chen, S., van der Meel, R., Thewalt, J. L., Tam, Y. Y. C., & Cullis, P. R. (2018) · ACS Nano · doi:10.1021/acsnano.8b01516 · Cited by 663 · see citing works

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., Long, Z., Chiang, Y. L., McGarrity, G. J., Muul, L. M., et al. (1997) · Nature Medicine · doi:10.1038/nm1297-1354 · Cited by 661 · see citing works

Brain Function and Blood Flow

Lassen, N. A., Ingvar, D. H., & Skinhöj, E. (1978) · Scientific American · doi:10.1038/scientificamerican1078-62 · Cited by 640 · see citing works

Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study

Collaborators, G. 2. U. N. D., Feigin, V. L., Vos, T., Alahdab, F., Amit, A. M. L., Bärnighausen, T. W., Beghi, E., Beheshti, M., Chavan, P. P., Criqui, M. H., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.4152 · Cited by 622 · see citing works

Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity

Whitehead, K. A., Dorkin, J. R., Vegas, A. J., Chang, P. H., Veiseh, O., Matthews, J., Fenton, O. S., Zhang, Y., Olejnik, K. T., Yesilyurt, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5277 · Cited by 615 · see citing works

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

Rosenblum, D., Gutkin, A., Kedmi, R., Ramishetti, S., Veiga, N., Jacobi, A. M., Schubert, M. S., Friedmann-Morvinski, D., Cohen, Z. R., Behlke, M. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc9450 · Cited by 614 · see citing works

Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing

Wei, T., Cheng, Q., Min, Y.-L., Olson, E. N., & Siegwart, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-17029-3 · Cited by 603 · see citing works

Lipid nanoparticles enabling gene therapies: from concepts to clinical utility

Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592 · see citing works

Receptor-mediated endocytosis

Wileman, T. E., Harding, C., & Stahl, P. D. (1985) · Biochemical Journal · doi:10.1042/bj2320001 · Cited by 566 · see citing works

Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation

Banks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., & Whiteside, T. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124407 · Cited by 561 · see citing works

Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation

Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549 · see citing works

α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

Kontopoulos, E., Parvin, J. D., & Feany, M. Β. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl243 · Cited by 539 · see citing works

Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles

Yanez Arteta, M., Kjellman, T., Bartesaghi, S., Wallin, S., Wu, X., Kvist, A. J., Dabkowska, A., Székely, N., Radulescu, A., Bergenholtz, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720542115 · Cited by 534 · see citing works

Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery

Chauhan, I., Yasir, M., Verma, M., & Singh, A. P. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.021 · Cited by 527 · see citing works

The dose threshold for nanoparticle tumour delivery

Ouyang, B., Poon, W., Zhang, Y.-N., Lin, Z. P., Kingston, B. R., Tavares, A. J., Zhang, Y., Chen, J., Valic, M. S., Syed, A. M., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-0755-z · Cited by 518 · see citing works

Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis

Qiu, M., Tang, Y., Chen, J., Muriph, R. E., Ye, Z., Huang, C., Evans, J. J., Henske, E. P., & Xu, Q. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116271119 · Cited by 508 · see citing works

Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates

Gray, S. J., Matagne, V., Bachaboina, L., Yadav, S., Ojeda, S. R., & Samulski, R. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.72 · Cited by 501 · see citing works

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

Nault, J.-C., Datta, S., Imbeaud, S., Franconi, A., Mallet, M., Couchy, G., Letouzé, E., Pilati, C., Verret, B., Blanc, J.-F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3389 · Cited by 489 · see citing works

Microstructural and Dynamical Heterogeneities in Ionic Liquids

Wang, Y., Li, B., Sarman, S., Mocci, F., Lu, Z., Yuan, J., Laaksonen, A., & Fayer, M. D. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00693 · Cited by 469 · see citing works

Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures

Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454 · see citing works

Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration

Carrasco, M. J., Alishetty, S., Alameh, M., Said, H., Wright, L., Paige, M. A., Soliman, O. Y., Weissman, D., Cleveland, T. E., Grishaev, A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02441-2 · Cited by 445 · see citing works

Rapid endothelial cytoskeletal reorganization enables early blood–brain barrier disruption and long-term ischaemic reperfusion brain injury

Shi, Y., Zhang, L., Pu, H., Mao, L., Hu, X., Jiang, X., Xu, N., Stetler, R. A., Zhang, F., Liu, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms10523 · Cited by 431 · see citing works

Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells

Filion, M. C., & Phillips, N. C. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00126-0 · Cited by 428 · see citing works

Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors

Gray, S. J., Foti, S. B., Schwartz, J. W., Bachaboina, L., Taylor-Blake, B., Coleman, J., Ehlers, M. D., Zylka, M. J., McCown, T. J., & Samulski, R. J. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.245 · Cited by 420 · see citing works

The age factor in Alzheimer’s disease

Guerreiro, R., & Bras, J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0232-5 · Cited by 415 · see citing works

Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease

Gray, M. T., & Woulfe, J. M. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.32 · Cited by 409 · see citing works

Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease

Roney, C. A., Kulkarni, P. V., Arora, V., Antich, P. P., Bonte, F. J., Wu, A., Mallikarjuana, N. N., Manohar, S. K., Liang, H., Kulkarni, A. R., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.024 · Cited by 408 · see citing works

Role of Monocarboxylate Transporters in Drug Delivery to the Brain

Vijay, N., & Morris, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990462 · Cited by 408 · see citing works

AAV serotype 2 vectors preferentially integrate into active genes in mice

Nakai, H., Montini, E., Fuess, S., Storm, T. A., Grompe, M., & Kay, M. A. (2003) · Nature Genetics · doi:10.1038/ng1179 · Cited by 392 · see citing works

Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles

Schlich, M., Palomba, R., Costabile, G., Mizrahy, S., Pannuzzo, M., Peer, D., & Decuzzi, P. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10213 · Cited by 387 · see citing works

Lactoferrin

Baker, E. N., & Baker, H. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5368-9 · Cited by 387 · see citing works

Long range electrostatic forces in ionic liquids

Gebbie, M. A., Smith, A. M., Dobbs, H. A., Lee, A. A., Warr, G. G., Banquy, X., Valtiner, M., Rutland, M. W., Israelachvili, J. N., Perkin, S., et al. (2016) · Chemical Communications · doi:10.1039/c6cc08820a · Cited by 384 · see citing works

Impact of particle elasticity on particle-based drug delivery systems

Anselmo, A. C., & Mitragotri, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.007 · Cited by 382 · see citing works

Ionic liquids for oral insulin delivery

Banerjee, A., Ibsen, K. N., Brown, T. D., Chen, R., Agatemor, C., & Mitragotri, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722338115 · Cited by 379 · see citing works

Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates

Gray, S. J., Nagabhushan Kalburgi, S., McCown, T. J., & Jude Samulski, R. (2013) · Gene Therapy · doi:10.1038/gt.2012.101 · Cited by 377 · see citing works

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

Brenner, J. S., Pan, D. C., Myerson, J. W., Marcos-Contreras, O. A., Villa, C. H., Patel, P., Hekierski, H., Chatterjee, S., Tao, J., Parhiz, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05079-7 · Cited by 371 · see citing works

Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core

Leung, A. K. K., Hafez, I. M., Baoukina, S., Belliveau, N. M., Zhigaltsev, I. V., Afshinmanesh, E., Tieleman, D. P., Hansen, C. L., Hope, M. J., & Cullis, P. R. (2012) · The Journal of Physical Chemistry C · doi:10.1021/jp303267y · Cited by 364 · see citing works

Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease

Agrawal, M., Ajazuddin, Tripathi, D. K., Saraf, S., Saraf, S., Antimisiaris, S. G., Mourtas, S., Hammarlund-Udenaes, M., & Alexander, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.019 · Cited by 356 · see citing works

Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease

Gao, H.-M., Zhang, F., Zhou, H., Kam, W., Wilson, B., & Hong, J.-S. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003013 · Cited by 355 · see citing works

Ionic liquids as a class of materials for transdermal delivery and pathogen neutralization

Zakrewsky, M., Lovejoy, K. S., Kern, T. L., Miller, T. E., Le, V., Nagy, A., Goumas, A. M., Iyer, R. S., Sesto, R. E. D., Koppisch, A. T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403995111 · Cited by 349 · see citing works

Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model11Published on the World Wide Web on 10 October 2000.

Björklund, A., Kirik, D., Rosenblad, C., Georgievska, B., Lundberg, C., & Mandel, R. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02915-2 · Cited by 346 · see citing works

State-of-the-art design and rapid-mixing production techniques of lipid nanoparticles for nucleic acid delivery

Evers, M. J. W., Kulkarni, J. A., van der Meel, R., Cullis, P. R., Vader, P., & Schiffelers, R. M. (2018) · Small Methods · doi:10.1002/smtd.201700375 · Cited by 332 · see citing works

Mitochondria in Ischemic Stroke: New Insight and Implications

Liu, F., Lu, J., Manaenko, A., Tang, J., & Hu, Q. (2018) · Aging and Disease · doi:10.14336/ad.2017.1126 · Cited by 326 · see citing works

Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems

Maeki, M., Kimura, N., Sato, Y., Harashima, H., & Tokeshi, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.008 · Cited by 320 · see citing works

Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns

Göppert, T. M., & Müller, R. H. (2005) · Journal of drug targeting · doi:10.1080/10611860500071292 · Cited by 299 · see citing works

Improved Anti-Tumor Effect of Liposomal Doxorubicin After Targeted Blood-Brain Barrier Disruption by MRI-Guided Focused Ultrasound in Rat Glioma

Treat, L. H., McDannold, N. J., Zhang, Y., Vykhodtseva, N. I., & Hynynen, K. (2012) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2012.04.015 · Cited by 296 · see citing works

Recent Advances in Ionic Liquids in Biomedicine

Curreri, A. M., Mitragotri, S., & Tanner, E. E. L. (2021) · Advanced Science · doi:10.1002/advs.202004819 · Cited by 291 · see citing works

Cancer nanotechnology: current status and perspectives

Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 277 · see citing works

Viral vectors for gene delivery to the central nervous system

Lentz, T. B., Gray, S. J., & Samulski, R. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.014 · Cited by 274 · see citing works

Transdermal insulin delivery using choline-based ionic liquids (CAGE)

Tanner, E. E. L., Ibsen, K. N., & Mitragotri, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.029 · Cited by 272 · see citing works

Nonbilayer phase of lipoplex–membrane mixture determines endosomal escape of genetic cargo and transfection efficiency

Zuhorn, I. S., Bakowsky, U., Polushkin, E., Visser, W. H., Stuart, M. C. A., Engberts, J. B. F. N., & Hoekstra, D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.018 · Cited by 268 · see citing works

Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma

Johnsen, K. B., Burkhart, A., Melander, F., Kempen, P. J., Vejlebo, J. B., Siupka, P., Nielsen, M. S., Andresen, T. L., & Moos, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11220-1 · Cited by 262 · see citing works

Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease

Hu, K., Shi, Y., Jiang, W., Han, J., Huang, S., & Jiang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.062 · Cited by 261 · see citing works

Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model

Wagner, S., Zensi, A., Wien, S., Tschickardt, S., Maier, W., Vogel, T., Worek, F., Pietrzik, C. U., Kreuter, J., & von Briesen, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032568 · Cited by 260 · see citing works

Anion Exchanger 1 (Band 3) Is Required to Prevent Erythrocyte Membrane Surface Loss but Not to Form the Membrane Skeleton

Peters, L. L., Shivdasani, R. A., Liu, S., Hanspal, M., John, K. M., Gonzalez, J. M., Brugnara, C., Gwynn, B., Mohandas, N., Alper, S. L., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80167-1 · Cited by 259 · see citing works

Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders

Schaser, A. J., Osterberg, V. R., Dent, S. E., Stackhouse, T. L., Wakeham, C. M., Boutros, S. W., Weston, L. J., Owen, N., Weissman, T. A., Luna, E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47227-z · Cited by 256 · see citing works

Lactate Transport and Signaling in the Brain: Potential Therapeutic Targets and Roles in Body—Brain Interaction

Bergersen, L. H. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.206 · Cited by 255 · see citing works

Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons

Guo, S., Kim, W. J., Lok, J., Lee, S.-R., Besancon, E., Luo, B.-H., Stins, M. F., Wang, X., Dedhar, S., & Lo, E. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801105105 · Cited by 253 · see citing works

CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells

Min, Y.-L., Li, H. Z., Rodríguez-Caycedo, C., Mireault, A. A., Huang, J. H., Shelton, J. M., McAnally, J., Amoasii, L., Mammen, P. P. A., Bassel‐Duby, R., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav4324 · Cited by 252 · see citing works

Transdermal Protein Delivery Using Choline and Geranate (CAGE) Deep Eutectic Solvent

Banerjee, A., Ibsen, K. N., Iwao, Y., Zakrewsky, M., & Mitragotri, S. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601411 · Cited by 249 · see citing works

Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy

Zhang, D., Wang, G., Yu, X., Wei, T., Farbiak, L., Johnson, L. T., Taylor, A. M., Xu, J., Hong, Y., Zhu, H., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01122-3 · Cited by 243 · see citing works

“You Shall Not Pass”—tight junctions of the blood brain barrier

Bauer, H., Krizbai, I. A., Bauer, H., & Traweger, A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00392 · Cited by 240 · see citing works

Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model

Virtanen, J. A., Cheng, K. H., & Somerharju, P. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4964 · Cited by 240 · see citing works

In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery

Jose, S., Anju, S. S., Cinu, T. A., Aleykutty, N., Thomas, S., & Souto, E. B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.003 · Cited by 237 · see citing works

What are lipoproteins doing in the brain?

Wang, H., & Eckel, R. H. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.10.003 · Cited by 234 · see citing works

Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA

Kulkarni, J. A., Myhre, J. L., Chen, S., Tam, Y. Y. C., Danescu, A., Richman, J. M., & Cullis, P. R. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.12.014 · Cited by 229 · see citing works

Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy

Kumar, V., Qin, J., Jiang, Y., Duncan, R. G., Brigham, B., Fishman, S., Nair, J. K., Akinc, A., Barros, S. A., & Kasperkovitz, P. V. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.61 · Cited by 222 · see citing works

Band 3, the human red cell chloride/bicarbonate anion exchanger (AE1, SLC4A1), in a structural context

Reithmeier, R. A. F., Casey, J. R., Kalli, A. C., Sansom, M. S. P., Alguel, Y., & Iwata, S. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.03.030 · Cited by 222 · see citing works

Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection

Ma, F., Yang, L., Sun, Z., Chen, J., Rui, X., Glass, Z., & Xu, Q. (2020) · Science Advances · doi:10.1126/sciadv.abb4429 · Cited by 218 · see citing works

Exploiting Endocytosis for NanomedicinesPreprint

Akinc, A., & Battaglia, G. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016980 · Cited by 211 · see citing works

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA

Blakney, A. K., McKay, P. F., Yus, B. I., Aldon, Y., & Shattock, R. J. (2019) · Gene Therapy · doi:10.1038/s41434-019-0095-2 · Cited by 206 · see citing works

Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier

Doll, D. N., Hu, H., Sun, J., Lewis, S. E., Simpkins, J. W., & Ren, X. (2015) · Stroke · doi:10.1161/strokeaha.115.009099 · Cited by 202 · see citing works

Monocarboxylate transport in erythrocytes

Deüticke, B. (1982) · The Journal of Membrane Biology · doi:10.1007/bf01870219 · Cited by 201 · see citing works

Relationship Between Amyloid-β Deposition and Blood–Brain Barrier Dysfunction in Alzheimer’s Disease

Wang, D., Chen, F., Han, Z., Yin, Z., Ge, X., & Lei, P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.695479 · Cited by 201 · see citing works

The Threshold Theory for Parkinson's Disease

Engelender, S., & Ole Isacson, A. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.10.008 · Cited by 194 · see citing works

Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain

Gupta, Y., Jain, A., & Jain, S. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.7.0004 · Cited by 193 · see citing works

Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers

Maeki, M., Fujishima, Y., Sato, Y., Yasui, T., Kaji, N., Ishida, A., Tani, H., Baba, Y., Harashima, H., & Tokeshi, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187962 · Cited by 192 · see citing works

Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells

D’souza, A. A., Burch, A. M., Dave, K. M., Sreeram, A., Reynolds, M. J., Dobbins, D. X., Kamte, Y. S., Zhao, W., Sabatelle, C., Joy, G. M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.038 · Cited by 192 · see citing works

Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth

Zelepukin, I. V., Yaremenko, A. V., Shipunova, V. O., Babenyshev, A., Balalaeva, I. V., Nikitin, P. I., Deyev, S. M., & Nikitin, M. P. (2018) · Nanoscale · doi:10.1039/c8nr07730d · Cited by 187 · see citing works

Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons

Makita, T., Sucov, H. M., Gariepy, C. E., Yanagisawa, M., & Ginty, D. D. (2008) · Nature · doi:10.1038/nature06859 · Cited by 185 · see citing works

Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier

Banks, W. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.005 · Cited by 184 · see citing works

Lipid Based Vesicular Drug Delivery Systems

Jain, S., Jain, V., & Mahajan, S. C. (2014) · Advances in Pharmaceutics · doi:10.1155/2014/574673 · Cited by 183 · see citing works

Localized RNAi Therapeutics of Chemoresistant Grade IV Glioma Using Hyaluronan-Grafted Lipid-Based Nanoparticles

Cohen, Z. R., Ramishetti, S., Peshes-Yaloz, N., Goldsmith, M., Wohl, A., Zibly, Z., & Peer, D. (2015) · ACS Nano · doi:10.1021/nn506248s · Cited by 182 · see citing works

Effect of Nanoparticle Composition, Size, Shape, and Stiffness on Penetration Across the Blood–Brain Barrier

Brown, T. D., Habibi, N., Wu, D., Lahann, J., & Mitragotri, S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00743 · Cited by 182 · see citing works

Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells

Basha, G., Novobrantseva, T. I., Rosin, N. L., Tam, Y. Y. C., Hafez, I. M., Wong, M., Sugo, T., Ruda, V. M., Qin, J., Klebanov, B., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.190 · Cited by 182 · see citing works

Correlation of the cytotoxic effects of cationic lipids with their headgroups

Cui, S., Wang, Y., Gong, Y., Lin, X., Zhao, Y., Zhi, D., Zhou, Q., & Zhang, S. (2018) · Toxicology Research · doi:10.1039/c8tx00005k · Cited by 180 · see citing works

Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor

Hsu, S., Yu, B., Wang, X., Lu, Y., Schmidt, C. R., Lee, R. J., Lee, L. J., Jacob, S. T., & Ghoshal, K. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.05.007 · Cited by 174 · see citing works

Characterization of Cytoplasmic α-Synuclein Aggregates

Lee, H.-J., & Lee, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208192200 · Cited by 173 · see citing works

Acute Direct Adenoviral Vector Cytotoxicity and Chronic, but Not Acute, Inflammatory Responses Correlate with Decreased Vector-Mediated Transgene Expression in the Brain

Thomas, C. E., Birkett, D., Anozie, I., Castro, M. G., & Lowenstein, P. R. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0224 · Cited by 173 · see citing works

ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier

Magro, R. D., Ornaghi, F., Cambianica, I., Beretta, S., Re, F., Musicanti, C., Rigolio, R., Donzelli, E., Canta, A., Ballarini, E., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.039 · Cited by 168 · see citing works

Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain

Rungta, R. L., Choi, H. B., Lin, P. J., Ko, R. W., Ashby, D., Nair, J., Manoharan, M., Cullis, P. R., & MacVicar, B. A. (2013) · Molecular Therapy—Nucleic Acids · doi:10.1038/mtna.2013.65 · Cited by 165 · see citing works

Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)

Kumari, S., Saad, M. A., Kumar, J. M., Kondapi, A. K., & Rao, N. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06888-4 · Cited by 164 · see citing works

Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma

Zhang, P., Miska, J. M., Lee-Chang, C., Rashidi, A., Panek, W. K., An, S., Ζαννίκου, Μ., Lopez‐Rosas, A., Han, Y., Xiao, T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906346116 · Cited by 162 · see citing works

Mechanism of Antibacterial Activity of Choline-Based Ionic Liquids (CAGE)

Ibsen, K. N., Ma, H., Banerjee, A., Tanner, E. E. L., Nangia, S., & Mitragotri, S. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00486 · Cited by 158 · see citing works

Comparison of Adeno-Associated Viral Vector Serotypes for Spinal Cord and Motor Neuron Gene Delivery

Snyder, B. R., Gray, S. J., Quach, E. T., Huang, J. W., Leung, C. H., Samulski, R. J., Boulis, N. M., & Federici, T. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.008 · Cited by 156 · see citing works

Erythrocyte leveraged chemotherapy (ELeCt): Nanoparticle assembly on erythrocyte surface to combat lung metastasis

Zhao, Z., Ukidve, A., Gao, Y., Kim, J., & Mitragotri, S. (2019) · Science Advances · doi:10.1126/sciadv.aax9250 · Cited by 151 · see citing works

ApoE Deficiency Compromises the Blood Brain Barrier Especially After Injury

Methia, N., André, P., Hafezi-Moghadam, A., Economopoulos, M., Thomas, K. L., & Wagner, D. D. (2001) · Molecular Medicine · doi:10.1007/bf03401973 · Cited by 150 · see citing works

Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**

Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie · doi:10.1002/ange.201203263 · Cited by 150 · see citing works

Endothelium-targeted overexpression of heat shock protein 27 ameliorates blood–brain barrier disruption after ischemic brain injury

Shi, Y., Jiang, X., Zhang, L., Pu, H., Hu, X., Zhang, W., Cai, W., Gao, Y., Leak, R. K., Keep, R. F., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621174114 · Cited by 149 · see citing works

Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels

Cunha, S., Forbes, B., Lobo, J. M. S., & Silva, A. C. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s305851 · Cited by 144 · see citing works

Modulation of Membrane Fusion by Asymmetric Transbilayer Distributions of Amino Lipids

Bailey, A. L., & Cullis, P. R. (1994) · Biochemistry · doi:10.1021/bi00208a007 · Cited by 143 · see citing works

Consideration for the scale‐up manufacture of nanotherapeutics—A critical step for technology transfer

Liu, X., & Meng, H. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200190 · Cited by 141 · see citing works

Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia

Nabhan, J. F., Wood, K. M., Rao, V. P., Morin, J., Bhamidipaty, S., LaBranche, T. P., Gooch, R. L., Bozal, F., Bulawa, C. E., & Guild, B. C. (2016) · Scientific Reports · doi:10.1038/srep20019 · Cited by 140 · see citing works

A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System

Wu, D., Qin, M., Xu, D., Wang, L., Liu, C., Ren, J., Zhou, G. W., Chen, C., Yang, F., Li, Y., et al. (2019) · Advanced Materials · doi:10.1002/adma.201807557 · Cited by 138 · see citing works

Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers

Brenner, J. S., Mitragotri, S., & Muzykantov, V. R. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-121219-024239 · Cited by 136 · see citing works

Tumor targeting of functionalized lipid nanoparticles: Assessment by in vivo fluorescence imaging

Goutayer, M., Dufort, S., Josserand, V., Royère, A., Heinrich, E., Vinet, F., Bibette, J., Coll, J., & Texier, I. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.02.007 · Cited by 135 · see citing works

ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood–Brain Barrier

Topal, G. R., Mészáros, M., Porkoláb, G., Szecskó, A., Polgár, T. F., Siklós, L., Deli, M. A., Veszelka, S., & Bozkır, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010038 · Cited by 133 · see citing works

Perfection of a synaptic receptor: kinetics and energetics of the acetylcholine receptor.

Jackson, M. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2199 · Cited by 133 · see citing works

The Neurovascular Unit in Glaucomatous Neurodegeneration

Wareham, L. K., & Calkins, D. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00452 · Cited by 131 · see citing works

Discovery of a Novel Amino Lipid That Improves Lipid Nanoparticle Performance through Specific Interactions with mRNA

Cornebise, M., Narayanan, E., Xia, Y., Acosta, E. P., Ci, L., Koch, H., Milton, J., Sabnis, S., Salerno, T., & Benenato, K. E. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106727 · Cited by 129 · see citing works

Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function

Ukidve, A., Zhao, Z., Fehnel, A., Krishnan, V., Pan, D. C., Gao, Y., Mandal, A., Muzykantov, V. R., & Mitragotri, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002880117 · Cited by 128 · see citing works

Human α-synuclein overexpression in a mouse model of Parkinson’s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation

Elabi, O. F., Gaceb, A., Carlsson, R., Padel, T., Soylu-Kucharz, R., Cortijo, I., Li, W., Li, J., & Paul, G. (2021) · Scientific Reports · doi:10.1038/s41598-020-80889-8 · Cited by 127 · see citing works

Regulation of cellular ATP release.

Fitz, J. (2007) · PubMed · Cited by 126 · see citing works

Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-mediated Delivery

Shi, B., Keough, E., Matter, A., Leander, K., Young, S., Carlini, E., Sachs, A. B., Tao, W., Abrams, M., Howell, B., et al. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411410885 · Cited by 125 · see citing works

Liposomes as targetable drug carriers.

Vp, T. (1985) · PubMed · Cited by 125 · see citing works

Nanoparticle‐Based Therapeutics for Brain Injury

Bharadwaj, V. N., Nguyen, D. T., Kodibagkar, V. D., & Stabenfeldt, S. E. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700668 · Cited by 125 · see citing works

Ionic liquid-mediated delivery of insulin to buccal mucosa

Vaidya, A., & Mitragotri, S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.037 · Cited by 125 · see citing works

Mechanistic study of transdermal delivery of macromolecules assisted by ionic liquids

Qi, Q. M., & Mitragotri, S. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.029 · Cited by 124 · see citing works

Targeting the blood-brain barrier for the delivery of stroke therapies

D’souza, A. A., Dave, K. M., Stetler, R. A., & Manickam, D. S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.015 · Cited by 122 · see citing works

Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E

Neves, A. R., Queiroz, J. F., Weksler, B., Romero, I. A., Couraud, P.-O., & Reis, S. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/49/495103 · Cited by 122 · see citing works

Monocarboxylic acid transporters, MCT1 and MCT2, in cortical astrocytes in vitro and in vivo

Hanu, R., McKenna, M. C., O’Neill, A., Resneck, W. G., & Bloch, R. J. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.5.c921 · Cited by 114 · see citing works

Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways

Neves, A. R., Queiroz, J. F., Lima, S. A. C., & Reis, S. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00705 · Cited by 113 · see citing works

Liposomes as delivery agents for medical imaging

Torchilin, V. P. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88805-8 · Cited by 109 · see citing works

Poststroke Induction of -Synuclein Mediates Ischemic Brain Damage

Kim, T., Mehta, S. L., Kaimal, B., Lyons, K. E., Dempsey, R. J., & Vemuganti, R. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1241-16.2016 · Cited by 106 · see citing works

Transdermal delivery of nobiletin using ionic liquids

Hattori, T., Tagawa, H., Inai, M., Kan, T., Kimura, S.-I., Itai, S., Mitragotri, S., & Iwao, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-56731-1 · Cited by 106 · see citing works

Ionic Liquids Induced Structural Changes of Bovine Serum Albumin in Aqueous Media: A Detailed Physicochemical and Spectroscopic Study

Singh, T., Bharmoria, P., Morikawa, M., Kimizuka, N., & Kumar, A. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp303609h · Cited by 105 · see citing works

Crosstalk between cerebral endothelium and oligodendrocyte

Miyamoto, N., Pham, L. D., Seo, J. H., Kim, K., Lo, E. H., & Arai, K. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1488-9 · Cited by 103 · see citing works

The Blood–Brain Barrier in Alzheimer's Disease

Sharma, H. S., Castellani, R. J., Smith, M. A., & Sharma, A. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00003-x · Cited by 102 · see citing works

Apicobasal polarity of brain endothelial cells

Worzfeld, T., & Schwaninger, M. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15608644 · Cited by 102 · see citing works

Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA

Lin, P. J. C., Tam, Y. Y. C., Hafez, I. M., Sandhu, A. P., Chen, S., Ciufolini, M. A., Nabi, I. R., & Cullis, P. R. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.019 · Cited by 101 · see citing works

A Novel Purification Method for CNS Projection Neurons Leads to the Identification of Brain Vascular Cells as a Source of Trophic Support for Corticospinal Motor Neurons

Dugas, J. C., Mandemakers, W. J., Rogers, M., Ibrahim, A., Daneman, R., & Barres, B. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2010-08.2008 · Cited by 99 · see citing works

The dissociation of acetylcholine from open nicotinic receptor channels

Grosman, C. F., & Auerbach, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251402498 · Cited by 97 · see citing works

Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood–brain barrier and glioma cells

Andresen, T. L., Bruun, J., Larsen, T. B., Jølck, R. I., Eliasen, R., Holm, R., & Gjetting, T. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87334 · Cited by 96 · see citing works

Ionization Behavior of Amino Lipids for siRNA Delivery: Determination of Ionization Constants, SAR, and the Impact of Lipid pKa on Cationic Lipid−Biomembrane Interactions

Zhang, J., Fan, H., Levorse, D. A., & Crocker, L. S. (2011) · Langmuir · doi:10.1021/la104590k · Cited by 95 · see citing works

Complications associated with intrathecal drug delivery systems

Delhaas, E. M., & Huygen, F. J. P. M. (2019) · BJA Education · doi:10.1016/j.bjae.2019.11.002 · Cited by 93 · see citing works

Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein

Davies, N. M., Hovdal, D., Edmunds, N. J., Nordberg, P., Dahlén, A., Dabkowska, A. P., Arteta, M. Y., Rădulescu, A., Kjellman, T., Höijer, A., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.03.008 · Cited by 88 · see citing works

Transferrin-functionalized lipid nanoparticles for curcumin brain delivery

Neves, A. R., van der Putten, L., Queiroz, J. F., Pinheiro, M., & Reis, S. (2021) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2021.03.010 · Cited by 87 · see citing works

Apolipoprotein E, Amyloid-β, and Blood-Brain Barrier Permeability in Alzheimer Disease

Donahue, J. E., & Johanson, C. E. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a0dc8 · Cited by 86 · see citing works

Functional Expression of Choline Transporters in the Blood–Brain Barrier

Inazu, M. (2019) · Nutrients · doi:10.3390/nu11102265 · Cited by 86 · see citing works

Liposome delivery to the brain with rapid short-pulses of focused ultrasound and microbubbles

Morse, S. V., Mishra, A., Chan, T. G., de Rosales, R. T. M., & Choi, J. J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.005 · Cited by 86 · see citing works

Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme

Jnaidi, R., Almeida, A. J., & Gonçalves, L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090860 · Cited by 84 · see citing works

Cross-linked antioxidant nanozymes for improved delivery to CNS

Klyachko, N. L., Manickam, D. S., Brynskikh, A. M., Uglanova, S. V., Li, S., Higginbotham, S. M., Bronich, T. K., Batrakova, E. V., & Kabanov, A. V. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.05.010 · Cited by 84 · see citing works

The blood-brain barrier choline transporter as a brain drug delivery vector

Allen, D. D., & Lockman, P. R. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00504-6 · Cited by 83 · see citing works

Drug Delivery Systems for Imaging and Therapy of Parkinson';s Disease

Silindir‐Gunay, M., Özer, A. Y., & Chalon, S. (2015) · Current Neuropharmacology · doi:10.2174/1570159x14666151230124904 · Cited by 81 · see citing works

Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice

Liu, M., Kuhel, D. G., Shen, L., Hui, D. Y., & Woods, S. C. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00219.2012 · Cited by 77 · see citing works

Localized viral vector delivery to enhance in situ regenerative gene therapy

Hu, W., Wang, Z., Hollister, S. J., & Krebsbach, P. H. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302940 · Cited by 76 · see citing works

Protein and mRNA Delivery Enabled by Cholesteryl‐Based Biodegradable Lipidoid Nanoparticles

Li, Y., Jarvis, R., Zhu, K., Glass, Z., Ogurlu, R., Gao, P., Li, P., Chen, J., Yu, Y., Yang, Y., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004994 · Cited by 75 · see citing works

Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors

Puhl, D. L., D’Amato, A. R., & Gilbert, R. J. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.05.024 · Cited by 72 · see citing works

Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity

Emami, J., Yousefian, H., & Sadeghi, H. (2018) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30117 · Cited by 70 · see citing works

Cell physiology and molecular mechanism of anion transport by erythrocyte band 3/AE1

Jennings, M. L. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00275.2021 · Cited by 69 · see citing works

Extracellular ATP Released by Osteoblasts Is A Key Local Inhibitor of Bone Mineralisation

Orriss, I. R., Key, M. L., Hajjawi, M. O. R., & Arnett, T. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069057 · Cited by 68 · see citing works

Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery

van der Meel, R., Chen, S., Zaifman, J., Kulkarni, J. A., Zhang, X. R. S., Tam, Y. K., Bally, M. B., Schiffelers, R. M., Ciufolini, M. A., Cullis, P. R., et al. (2021) · Small · doi:10.1002/smll.202103025 · Cited by 68 · see citing works

The generation and function of soluble apoE receptors in the CNS

Rebeck, G. W., LaDu, M. J., Estus, S., Bu, G., & Weeber, E. J. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-15 · Cited by 66 · see citing works

Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting

Shobaki, N., Sato, Y., & Harashima, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s188016 · Cited by 65 · see citing works

Protein-avoidant ionic liquid (PAIL)–coated nanoparticles to increase bloodstream circulation and drive biodistribution

Hamadani, C. M., Goetz, M. J., Mitragotri, S., & Tanner, E. E. L. (2020) · Science Advances · doi:10.1126/sciadv.abd7563 · Cited by 64 · see citing works

Delivery of mitochondria via extracellular vesicles – A new horizon in drug delivery

Manickam, D. S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.045 · Cited by 61 · see citing works

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

Wang, J., Ding, Y., Chong, K. C., Cui, M., Cao, Z., Tang, C., Tian, Z., Hu, Y., Zhao, Y., & Jiang, S. (2024) · Vaccines · doi:10.3390/vaccines12101148 · Cited by 246 · see citing works

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

Shi, Y., Shi, M., Wáng, Y., & You, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02002-z · Cited by 231 · see citing works

Ionic liquids revolutionizing biomedicine: recent advances and emerging opportunities

Hu, Y., Xing, Y., Yue, H., Chen, T., Diao, Y., Wei, W., & Zhang, S. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00510k · Cited by 145 · see citing works

SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors

Sun, Q., Xing, X., Wang, H., Wan, K., Fan, R., Liu, C., Wang, Y., Wu, W., Wang, Y., & Wang, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115586 · Cited by 123 · see citing works

Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity

Wu, L., Li, X., Qian, X., Wang, S., Liu, J., & Yan, J. (2024) · Vaccines · doi:10.3390/vaccines12020186 · Cited by 125 · see citing works

Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment

Zhao, C., Zhu, X., Tan, J., Mei, C., Cai, X., & Kong, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116113 · Cited by 74 · see citing works

Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing

Han, E. L., Padilla, M. S., Palanki, R., Kim, D., Mrksich, K., Li, J. J., Tang, S., Yoon, I.-C., & Mitchell, M. J. (2024) · Nano Letters · doi:10.1021/acs.nanolett.3c03509 · Cited by 72 · see citing works

Applications of Metal–Organic Frameworks (MOFs) in Drug Delivery, Biosensing, and Therapy: A Comprehensive Review

Saboorizadeh, B., Zare‐Dorabei, R., Safavi, M., & Safarifard, V. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c02795 · Cited by 70 · see citing works

Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group

Cavazza, A., Molina-Estévez, F. J., Reyes, Á. P., Ronco-Díaz, V., Naseem, A., Malenšek, Š., Pečan, P., Santini, A., Heredia, P., Aguilar-González, A., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102457 · Cited by 70 · see citing works

Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases

Khalil, A., Barras, A., Boukherroub, R., Tseng, C., Devos, D., Burnouf, T. P. R., Neuhaus, W., & Szunerits, S. (2023) · Nanoscale Horizons · doi:10.1039/d3nh00306j · Cited by 62 · see citing works

Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma

Branco, F., Cunha, J., Mendes, M., Vitorino, C., & Sousa, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c01790 · Cited by 58 · see citing works

Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders

Wu, Y., & Angelova, A. (2023) · Nanomaterials · doi:10.3390/nano13233004 · Cited by 53 · see citing works

Advances in local drug delivery technologies for improved rheumatoid arthritis therapy

An, X., Yang, J., Cui, X., Zhao, J., Jiang, C., Tang, M., Dong, Y., Lin, L., Li, H., & Wang, F. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115325 · Cited by 45 · see citing works

Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases

Moosavi, S. G., Rahiman, N., Jaafari, M. R., & Arabi, L. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113641 · Cited by 52 · see citing works

Nanotherapy of Glioblastoma—Where Hope Grows

Grzegorzewski, J., Michalak, M., Wołoszczuk, M., Bulicz, M., & Majchrzak‐Celińska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051814 · Cited by 42 · see citing works

Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis

Li, Y., Liu, R., & Zhao, Z. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010109 · Cited by 40 · see citing works

Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: A comprehensive review

Saoud, R. A., Hamrouni, A., Idris, A., Mousa, W. K., & Izneid, T. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115091 · Cited by 37 · see citing works

Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics

Ronaldson, P. T., & Davis, T. P. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2306138 · Cited by 40 · see citing works

Inhalable mRNA Nanoparticle with Enhanced Nebulization Stability and Pulmonary Microenvironment Infiltration

Jang, M., Yeom, K., Han, J., Fagan, E., & Park, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c05653 · Cited by 37 · see citing works

Advanced Nanomedicines for Treating Refractory Inflammation-Related Diseases

Wang, X., Song, X., Feng, W., Chang, M., Yang, J., & Chen, Y. (2025) · Nano-Micro Letters · doi:10.1007/s40820-025-01829-7 · Cited by 41 · see citing works

Tissue-Resident Macrophage Membrane-Coated Nanomedicine for Targeted Tumor Therapy

Su, X., Su, M., Guo, E., Zhou, Y., Yang, X., Li, S., & Ye, Y. (2025) · ACS Nano · doi:10.1021/acsnano.5c04463 · Cited by 33 · see citing works

Synergistic integration of mRNA-LNP with CAR-engineered immune cells: Pioneering progress in immunotherapy

Chen, Z., Shu, J., Hu, Y., & Mei, H. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.09.019 · Cited by 31 · see citing works

3D printing of drug delivery systems enhanced with micro/nano-technology

Zhu, H., Kuang, H., Huang, X., Li, X., Zhao, R., Shang, G., Wang, Z., Liao, Y.-C., He, J., & Li, D. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115479 · Cited by 32 · see citing works

Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design

Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · Pharmaceuticals · doi:10.3390/ph18050607 · Cited by 35 · see citing works

The autophagy–lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson’s disease

Jiao, F., Meng, L., Du, K., & Li, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01195 · Cited by 28 · see citing works

Nanomaterials Boost CAR‐T Therapy for Solid Tumors

Long, J., Wang, Y., Jiang, X., Ge, J., Chen, M., Zheng, B., Wang, R., Wang, M., Xu, M., Qi, K., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304615 · Cited by 28 · see citing works

Optimizing Peptide-Conjugated Lipid Nanoparticles for Efficient siRNA Delivery across the Blood–Brain Barrier and Treatment of Glioblastoma Multiforme

Tong, H., Ma, Z., Yu, J., Li, D., Zhu, Q., Shi, H., Wu, Y., Yang, H., Zheng, Y., Sun, D., et al. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00039 · Cited by 28 · see citing works

Selective homing of brain-derived reconstituted lipid nanoparticles to cerebral ischemic area enables improved ischemic stroke treatment

Han, D., Wang, M., Dong, N., Zhang, J., Li, D., Ma, X., Ma, Y., Wang, S., Zhu, Y., & Wang, C. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.020 · Cited by 27 · see citing works

Advances in drug delivery systems based on liposome-composite hydrogel microspheres

Yang, S., Li, Y., Li, S., Zhang, J., Huang, J., Ren, J., & Wu, X. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01369k · Cited by 27 · see citing works

The piper at the gates of brain: A systematic review of surface modification strategies on lipid nanoparticles to overcome the Blood-Brain-Barrier

Vargas, R., Lizano-Barrantes, C., Romero-Obón, M., València-Clua, K., Narváez-Narváez, D. A., Suñé-Negre, J. M., Pérez‐Lozano, P., García‐Montoya, E., Martínez-Martínez, N., Hernández-Munaín, C., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124686 · Cited by 24 · see citing works

Engineered extracellular vesicles: an emerging nanomedicine therapeutic platform

Tang, J., Li, D., Wang, R., Li, S., Xing, Y., & Yu, F. (2025) · Chemical Communications · doi:10.1039/d4cc06501h · Cited by 24 · see citing works

A manifesto for Alzheimer’s disease drug discovery in the era of disease-modifying therapies

Hering, H., Bussière, T., Liu, C., Glajch, K. E., Weihofen, A., Grogan, J. L., & Walsh, D. M. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00872-7 · Cited by 26 · see citing works

Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases

Razavi, R., Kegel, M., Muscat-Rivera, J., Weissman, D., & Melamed, J. R. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101566 · Cited by 25 · see citing works

Menthol-Modified Quercetin Liposomes with Brain-Targeting Function for the Treatment of Senescent Alzheimer’s Disease

Liu, W., Yu, Y., Zang, J., Liu, Y., Li, F.-R., Zhang, L., Guo, R., Kong, L., Ma, L.-Y., & Li, X. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00109 · Cited by 23 · see citing works

Advances in structural-guided modifications of siRNA

Li, Q., Dong, M., & Chen, P. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117825 · Cited by 23 · see citing works

Combating Gram-negative infections: The role of antimicrobial peptides and nanotechnology in overcoming antibiotic resistance

Canales, C. S. C., Cazorla, J. I. M., Cazorla, R. M. M., Sábio, R. M., Santos, H. A., & Pavan, F. R. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102381 · Cited by 23 · see citing works

Next-generation nanocarriers for precision antitumor therapy: from passive targeting to intelligent response

Singh, D., & Kumar, A. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002355 · Cited by 23 · see citing works

Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy

Qi, J., Zhang, L., Ren, Z., Yuan, Y., Yu, J., Zhang, Y., Gu, L., Wang, X., Wang, Y., Xu, H., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02776-y · Cited by 22 · see citing works

Metal–Organic Frameworks for Overcoming the Blood–Brain Barrier in the Treatment of Brain Diseases: A Review

Nabipour, H., & Rohani, S. (2024) · Nanomaterials · doi:10.3390/nano14171379 · Cited by 22 · see citing works

Nanoparticle-based strategy in CAR-T cell immunotherapy: challenges, implications, and perspectives

Shang, D., Zhou, Z., Shi, R., Wang, Z., Zhang, P., Fu, P., Li, H., Cheng, G., Qin, H., Xie, Z., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02476-7 · Cited by 22 · see citing works

Endothelial cell‐specific reduction in mTOR ameliorates age‐related arterial and metabolic dysfunction

Islam, M. T., Hall, S. A., Dutson, T., Bloom, S. I., Bramwell, R. C., Kim, J., Tucker, J. R., Machin, D. R., Donato, A. J., & Lesniewski, L. A. (2023) · Aging Cell · doi:10.1111/acel.14040 · Cited by 22 · see citing works

Trajectory of brain-derived amyloid beta in Alzheimer’s disease: where is it coming from and where is it going?

Liu, N., Haziyihan, A., Zhao, W. G., Chen, Y., & Chao, H. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00434-9 · Cited by 21 · see citing works

A new strategy for the extrahepatic delivery of lipid-based nanomedicines: a protein corona-mediated selective targeting system based on an ionizable cationic lipid library

Younis, M. A., Sato, Y., Kimura, S., & Harashima, H. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00079c · Cited by 22 · see citing works

Strategies for enhanced gene delivery to the central nervous system

Gao, Z. (2024) · Nanoscale Advances · doi:10.1039/d3na01125a · Cited by 24 · see citing works

Challenges and material innovations in drug delivery to central nervous system tumors

Gong, Z., Zhou, D., Wu, D., Han, Y., Yu, H. Q., Shen, H., Feng, W., Hou, L., Chen, Y., & Xu, T. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123180 · Cited by 22 · see citing works

Emerging Strategies for Immunotherapy of Solid Tumors Using Lipid‐Based Nanoparticles

Fernandes, S., Cassani, M., Cavalieri, F., Forte, G., & Caruso, F. (2023) · Advanced Science · doi:10.1002/advs.202305769 · Cited by 20 · see citing works

Nanocarrier-mediated siRNA delivery: a new approach for the treatment of traumatic brain injury–related Alzheimer’s disease

Jin, J., Zhang, H., Lu, Q., Tian, L., Yao, S., Lai, F., Liang, Y., Liu, C., Lu, Y., Tian, S., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00303 · Cited by 20 · see citing works

Ionic liquid-coated lipid nanoparticles increase siRNA uptake into CNS targets

Khare, P., Edgecomb, S. X., Hamadani, C. M., Conway, J. F., Tanner, E. E. L., & Manickam, D. S. (2023) · Nanoscale Advances · doi:10.1039/d3na00699a · Cited by 19 · see citing works

Harnessing Microfluidics for the Effective and Precise Synthesis of Advanced Materials

Qi, X., & Hu, G. (2025) · Micromachines · doi:10.3390/mi16101106 · Cited by 18 · see citing works

Virus-Inspired Glucose and Polydopamine (GPDA)-Coating as an Effective Strategy for the Construction of Brain Delivery Platforms

Duan, Q.-J., Liu, R., Luo, J., Zhang, J., Zhou, Y., Zhao, J., & Du, J. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c04175 · Cited by 18 · see citing works

Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies

Vargas, R., Martínez-Martínez, N., Lizano-Barrantes, C., Molina, J. A. P., García‐Montoya, E., Pérez‐Lozano, P., Suñé-Negre, J. M., Suñé, C., & Suñé-Pou, M. (2025) · ADMET & DMPK · doi:10.5599/admet.2988 · Cited by 17 · see citing works

Nanoparticles: a new frontier in neurodegenerative disease therapy

Kumar, V., Sharma, S., & Singh, A. K. (2025) · Frontiers in Medical Technology · doi:10.3389/fmedt.2025.1654003 · Cited by 20 · see citing works

Lipoplexes’ Structure, Preparation, and Role in Managing Different Diseases

El‐Zahaby, S. A., Kaur, L., Sharma, A., Prasad, A. G., Wani, A. K., Singh, R., & Zakaria, M. Y. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02850-6 · Cited by 18 · see citing works

Liposomal Nanomaterials: A Rising Star in Glioma Treatment

Gan, Y., Yu, Y., Xu, H., & Piao, H. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s470478 · Cited by 17 · see citing works

Circular mRNA Vaccine against SARS-COV-2 Variants Enabled by Degradable Lipid Nanoparticles

Huang, K., Li, N., Li, Y., Zhu, J., Fan, Q., Yang, J., Gao, Y., Liu, Y., Gao, S., Zhao, P., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c20770 · Cited by 32 · see citing works

Engineered lipid nanoparticles with synergistic dendritic cell targeting and enhanced endosomal escape for boosted mRNA cancer vaccines

Wang, S., Zheng, J., Zhou, J., Jiang, W., Chen, Z., Wu, X., Guo, B., Wu, Y., & Yang, F. H. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102107 · Cited by 16 · see citing works

Therapies for Mitochondrial Disease: Past, Present, and Future

Ball, M., Bergen, N. J. V., Compton, A. G., Thorburn, D. R., Rahman, S., & Christodoulou, J. (2025) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.70065 · Cited by 15 · see citing works

A fully iPS-cell-derived 3D model of the human blood–brain barrier for exploring neurovascular disease mechanisms and therapeutic interventions

González-Gallego, J., Völgyi, K., Müller, S. A., Antesberger, S., Todorov, M. I., Malik, R., Grimalt-Mirada, R., Gonçalves, C. C., Schifferer, M., Kislinger, G., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02123-w · Cited by 16 · see citing works

Long-acting nanomedicine for brain diseases

Liao, J., Huang, Q., Li, R., Gong, L., Li, T., & Lin, Z. X. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114665 · Cited by 14 · see citing works

Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood–brain-barrier and glioblastoma stem cells

Zhao, C., Zhu, X., Yang, H., Tan, J., Gong, R., Mei, C., Cai, X., Su, Z., & Kong, F. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad6e47 · Cited by 14 · see citing works

Multivariate Optimization of Carbamazepine-Loaded Nanostructured Lipid Carriers for Brain Targeting and Epilepsy Management

Patel, P., Vaidya, R., Kansara, Y., Shah, P., Kapoor, D. U., & Prajapati, B. G. (2024) · BioNanoScience · doi:10.1007/s12668-024-01624-5 · Cited by 14 · see citing works

LncRNA regulation in ischemic stroke and their application prospects

Chen, Q., Xu, X., Li, S., & Xiong, T. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00924 · Cited by 13 · see citing works

Nanoparticles and Nanomaterials: A Review from the Standpoint of Pharmacy and Medicine

Petrov, G. V., Koldina, A. M., Ledenev, O. V., Tumasov, V. N., Nazarov, A. V., & Syroeshkin, A. V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050655 · Cited by 13 · see citing works

Sperm and offspring production in a nonobstructive azoospermia mouse model via testicular mRNA delivery using lipid nanoparticles

Mashiko, D., Emori, C., Hatanaka, Y., Motooka, D., Chen, P., Kaneda, Y., Matzuk, M. M., & Ikawa, M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2516573122 · Cited by 12 · see citing works

TET1-Lipid Nanoparticle Encapsulating Morphine for Specific Targeting of Peripheral Nerve for Pain Alleviation

Yang, H., Liu, Z., Liu, F., Wu, H., Huang, X., Huang, R., Saw, P. E., & Cao, M. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s453608 · Cited by 12 · see citing works

Vectors in CRISPR Gene Editing for Neurological Disorders: Challenges and Opportunities

Xiong, K., Wang, X., Feng, C., Zhang, K., Chen, D., & Yang, S. (2025) · Advanced Biology · doi:10.1002/adbi.202400374 · Cited by 12 · see citing works

Targeted miRNA Delivery in Epilepsy: Mechanisms, Advances, and Therapeutic Potential

Shyam, M., Bm, O., Srirangan, P., Nivedita, N., & Sabina, E. P. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10436-z · Cited by 12 · see citing works

Celery seed derived reconstituted lipid nanoparticles as an innate neuron-targeted neuroprotective nanomedicine for ischemic stroke treatment

Han, D., Zhang, J., Li, D., & Wang, C. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03372-4 · Cited by 11 · see citing works

Developing a Ready-to-Use Lipid Nanoparticle Technology for Nucleic Acid Delivery Based on Deep Eutectic Solvents

Wei, Y., Kong, W., Dong, Z., Liu, W., Lu, X., Yang, P., Zhao, J., Feng, J., Wei, Z., Yang, J., et al. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c04665 · Cited by 10 · see citing works

Comparison of Drug Delivery Systems with Different Types of Nanoparticles in Terms of Cellular Uptake and Responses in Human Endothelial Cells, Pericytes, and Astrocytes

Sahin, H., Yücel, O., Holloway, P. H., Yıldırım, E., Emik, S., Gürdağ, G., Tanrıverdi, G., & Şentürk, G. E. (2024) · Pharmaceuticals · doi:10.3390/ph17121567 · Cited by 10 · see citing works

Exploring Framework Nucleic Acids: A Perspective on Their Cellular Applications

Wang, Z., Wang, X., He, Y., Wu, H. C., Mao, R., Wang, H., & Qiu, L. (2024) · JACS Au · doi:10.1021/jacsau.4c00776 · Cited by 9 · see citing works

A novel dual-targeting strategy of nanobody-driven protein corona modulation for glioma therapy

Zhang, Y., Qin, S., Song, T., Huang, Z., Lv, Z., Zhao, Y. C., Jiao, X., Sun, M., Zhang, Y., Xie, G., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.014 · Cited by 9 · see citing works

Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer’s disease and Parkinson’s disease

Li, Y., Zhang, J., Ma, B., Yu, W., Xu, M., Luan, W., Yu, Q., Zhang, L., Rong, R., Fu, Y., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124786 · Cited by 9 · see citing works

Suppressor tRNAs as personalized therapy for nonsense mutation-associated pathologies

Ignatova, Z., & Albers, S. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108919 · Cited by 8 · see citing works

Tuning the polyethylene glycol-lipid anchor length of lipid nanoparticles to enhance brain-targeted siRNA delivery

Tong, H., Ma, Z., Li, D., Yu, J., Zhu, Q., Shi, H., Zheng, Y., Li, Z., Li, H., Lv, P., et al. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.10.018 · Cited by 8 · see citing works

New Transferrin Receptor‐Targeting Conjugate Effectively Delivers DNA to Mouse Brain

Song, M.-S., Bustos, A. H., Bastue, L. B., Mikutavicius, J., Swiderski, P. M., Clemens, K. J., Habib, N. A., Rossi, J. J., & Astakhova, K. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202500247 · Cited by 7 · see citing works

Sanggenol L Enhances Temozolomide Drug Sensitivity by Inhibiting Mitophagy and Inducing Apoptosis Through the Regulation of the TRIM16‐OPTN Axis in Glioblastoma

Chang, H., Hou, J., Hu, X., Hou, N., Xu, M., Du, Y., Xu, J., Wang, Y., Xie, Z., Shi, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202502915 · Cited by 6 · see citing works

Wearable Contact Lenses for Advanced Ocular Drug Delivery: Progress and Challenges

Wang, Z., Zhou, Y., Lin, Q., Zhang, X., Qiao, M., Dong, L., & Sun, G. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202518446 · Cited by 6 · see citing works

Targeted nanodelivery strategies for atrial fibrillation: concomitant targeting of fibrosis suppression and electrical conduction restoration through advanced nanobiotechnology

Liang, Y., Zheng, H., & Tian, Y. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03822-z · Cited by 6 · see citing works

Comprehensive Evaluation of Human and Murine Protein Coronae Formed on Choline Carboxylic Acid Ionic Liquid-Modified PLGA Nanoparticles

Chism, C. M., Sepehri, B., Guérin, N., Heintz, R., Hamadani, C. M., Hoang, A., Shami, A. A., Vanlandingham, M. B., Dasanayake, G. S., Jarrett, E., et al. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00347 · Cited by 6 · see citing works

Fabrication of Hyaluronic Acid‐Targeted Supramolecular Delivery Platform With pH and ROS‐Responsive Drug Release

Jiang, K., Wu, W., Xie, M., He, H., & Sun, R. (2025) · Macromolecular Rapid Communications · doi:10.1002/marc.202500201 · Cited by 6 · see citing works

High-Throughput In Vivo Screening Identifies Structural Factors Driving mRNA Lipid Nanoparticle Delivery to the Brain

Han, E. L., Kim, D., Murray, A. M., Mrksich, K., Hamilton, A. G., Tang, S., Yoo, S., Zhu, A. T., Tong, E. R., Palanki, R., et al. (2026) · ACS Nano · doi:10.1021/acsnano.5c19138 · Cited by 5 · see citing works

Starlike Au nanoparticle unleashing siDDIT3 and photothermal power to combat ferroptosis - driven osteoarthritis

Wang, C., Hua, S., Feng, T., Zheng, Y., Hu, Y., Zhao, C., Wang, S., Hu, Y., Zhou, M., & Feng, L. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03563-z · Cited by 5 · see citing works

Ionic liquids revolutionizing drug delivery: Recent advances and emerging opportunities

Wu, X., Tai, Z., Li, Y., Zhu, C., Yu, Q., Yin, B., Chu, X., Wang, H., Zhu, Q., & Chen, Z. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114355 · Cited by 5 · see citing works

Nanomaterials in stimulus-responsive drug delivery systems facilitate precise therapy for hematologic diseases

Li, L., Jiang, W., & Qiu, S. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00807g · Cited by 5 · see citing works

siRNA-based therapy for gastric adenocarcinoma: what’s next step?

Salman, D. M., & Mohammad, T. A. M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155328 · Cited by 5 · see citing works

LNP-mRNA delivers TNF-α antibody to deep cartilage and protects against osteoarthritis

Li, B., Cui, L., Kong, K., Pang, Y., Chen, Y., Zhang, S., Wang, F., Zhou, T., Hua, Y., Mi, C., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.156723 · Cited by 5 · see citing works

Systemic mRNA-LNP administration in fetuses improves survival in a mouse model of spinal muscular atrophy

Carpenter, M. D., Kus, N. J., Choi, R. B., Said, H., Dumitru, A. M., Bauer, J. H., Wang, S., Luks, V. L., Teerdhala, S., Shah, A., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101599 · Cited by 6 · see citing works

Engineered neural stem cell vesicles activating Wnt promote blood–brain barrier repair after cerebral haemorrhage

Li, T., Wang, P., Li, F., Chen, K., Yu, J., Ma, C., Fan, X., Zhong, J., Tang, Q., Wang, X., et al. (2025) · Brain · doi:10.1093/brain/awaf381 · Cited by 4 · see citing works

Skeleton keys and Trojan horses: a review of therapeutic delivery to the brain

Stoub, R. E., & Bailus, B. J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1674333 · Cited by 4 · see citing works

Tumor cell membrane camouflaged liposomal pharmaceuticals for cascade catalysis‐driven redox modulation and synergistic ROS/RNS antitumor therapy

Zheng, G., Ke, T., Wang, H., Huang, H., Zhang, Y., Fei, G., Liao, C., & Yang, H. (2026) · Open Research (University of Surrey) · doi:10.1002/viw.20250198 · Cited by 4 · see citing works

Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer

Yang, R., Liu, Y., Yang, N., Zhang, T., Hou, J., He, Z., Wang, Y., Sun, X., Shen, J., Jiang, H., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040570 · Cited by 4 · see citing works

Iron oleate containing lipid nanoparticles prepared by gradient solvent diffusion method for oxidative stress dependent antibacterial therapy

Zhou, Y., Yan, Z., Wang, Q., Wang, X., Jiang, X., Wang, X., Shi, H., & Wang, C. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125264 · Cited by 4 · see citing works

Lipid Nanoparticle-Mediated Targeted Delivery of MEGF10 siRNA to Astrocytes Reduced Synaptic Phagocytosis and Promoted Stroke Recovery in Mice

Xu, T., Chang, Y., Wang, R., Xu, J., Qian, D., Yao, H., Gan, L., Deng, S., Lian, Q., Ye, J., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c13954 · Cited by 4 · see citing works

Recent advances and clinical prospects of non-viral brain-targeted gene delivery systems

Wang, S., Xu, L.-L., Ma, F., Xu, M., Chen, G., Wang, D., Wu, X., Wang, P., Yu, J., & Shi, L. (2025) · Applied Physics Reviews · doi:10.1063/5.0255745 · Cited by 4 · see citing works

Ionic liquid-coated lipid nanoparticles demonstrate prolonged circulation and brain uptake via red blood cell hitchhiking

Khare, P., Edgecomb, S. X., Hamadani, C. M., Hu, D., Govindaswamy, B., Taylor, G. R., Caprara, R., Tanner, E. E. L., & Manickam, D. S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114487 · Cited by 4 · see citing works

Central Nervous System Targeting Nanovesicles for Trans-Barrier Delivery and Spinal Cord Injury Treatment

Wang, J., Chen, J., Chen, J., Xia, K., Yuan, P., Zhou, X., Wang, R., Yu, C., Li, Y., Shi, K., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c08255 · Cited by 4 · see citing works

An autonomous siRNA delivery system targeting NLRP3: implications in Parkinson’s disease

Lin, L., Li, Z., Su, F., Huang, H., Huang, S., Chen, W., Zheng, J., Yu, H., Li, F. Z., Du, X., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04688-0 · Cited by 4 · see citing works

Ionic liquids and their potential use in development and improvement of drug delivery systems: evidence of their tendency to promote drug accumulation in the brain

Eades, W. C., Abdolmohammadpourbonab, S., Đinh, L., & Yan, B. (2024) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2024.2417004 · Cited by 4 · see citing works

ATP11B triggers the infiltration of T cells into GBM and intensifies anti-GBM immunity by upregulating and externalizing S1PR1

Qiu, H., Chen, Z., Chen, J., Yu, H., Wen, X., Xu, C., Liu, G., Chai, L., Zhang, L., Guo, Y., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06594-0 · Cited by 4 · see citing works

Brain delivery of lipid nanoparticles with shuttle peptides

Martínez-Martínez, N., CARRERA-RODRÍGUEZ, L., Vargas, R., Hernández-Munaín, C., Suñé-Pou, M., & Suñé, C. M. I. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.02.005 · Cited by 1 · see citing works

Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer

Cai, X., Drummond, C. J., Zhai, J., & Tran, N. L. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202404234 · Cited by 72 · see citing works

role of lipid based nanoparticles in brain targeted drug delivery system

Kumar, K. P., Nihal, P. M., Bandari, N., Iswariya, V. T., Rao, A. H. O. P., Rana, R., & Kaushik, S. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.8628 · Cited by 2 · see citing works

Lipid nanoparticles functionalization strategies to cross the blood-brain-barrier.

Vargas, R., Narváez-Narváez, D. A., Moreno‐Castro, C., Nardi-Ricart, A., Peréz-Lozano, P., García-Montoya, E., Suñé-Negre, J. M., Hernández-Munaín, C., Suñé, C., & Suñé-Pou, M. (2022) · DIGITAL.CSIC (Spanish National Research Council (CSIC))

High-Throughput In Vivo Screening Identifies Structural Factors Driving mRNA Lipid Nanoparticle Delivery to the Brain

Han, E. L., Kim, D., Murray, A. M., Mrksich, K., Hamilton, A. G., Tang, S., Yoo, S., Zhu, A. T., Tong, E. R., Palanki, R., et al. (2026) · ACS Nano · doi:10.1021/acsnano.5c19138 · Cited by 5 · see citing works